216 related articles for article (PubMed ID: 25901588)
1. Use of oral formulations of fentanyl for breakthrough cancer pain.
Handsaker S; Dempsey L; Fabby C
Int J Palliat Nurs; 2015 Apr; 21(4):168, 170-2. PubMed ID: 25901588
[No Abstract] [Full Text] [Related]
2. Are there cost benefits to fentanyl for breakthrough pain?
Davis MP
J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
[No Abstract] [Full Text] [Related]
3. Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
Núñez-Olarte JM; Alvarez-Jiménez P
J Pain Symptom Manage; 2011 Dec; 42(6):e6-8. PubMed ID: 22048003
[No Abstract] [Full Text] [Related]
4. Fentanyl pectin nasal spray for breakthrough cancer pain.
Torres LM; Trinidad JM; Calderón E; Benitez D; Perelman M
Int J Palliat Nurs; 2015 Mar; 21(3):114-6. PubMed ID: 25815759
[No Abstract] [Full Text] [Related]
5. Fentanyl pectin nasal spray for breakthrough cancer pain.
Taylor DR; Gabrail N
Future Oncol; 2012 Feb; 8(2):121-30. PubMed ID: 22335576
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG
PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672
[TBL] [Abstract][Full Text] [Related]
7. The pharmacoeconomics of breakthrough cancer pain.
Kuo KL; Saokaew S; Stenehjem DD
J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):167-75. PubMed ID: 23688496
[TBL] [Abstract][Full Text] [Related]
8. Fast-acting fentanyl preparations and pain management.
McWilliams K; Fallon M
QJM; 2013 Oct; 106(10):887-90. PubMed ID: 23613597
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
Mercadante S; Ferrera P; Adile C; Casuccio A
J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Opioids for the management of breakthrough pain in cancer patients.
Zeppetella G; Davies AN
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD004311. PubMed ID: 26275024
[TBL] [Abstract][Full Text] [Related]
11. [Management of breakthrough cancer pain].
Sláma O
Klin Onkol; 2013; 26(3):191-4. PubMed ID: 23763322
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based treatment of cancer-related breakthrough pain with opioids.
Zeppetella G
J Natl Compr Canc Netw; 2013 Mar; 11 Suppl 1():S37-43. PubMed ID: 23520185
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Oral or Nasal Fentanyl for Treatment of Breakthrough Pain in Cancer Patients: A Systematic Review.
Rogríguez D; Urrutia G; Escobar Y; Moya J; Murillo M
J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):228-46. PubMed ID: 26458018
[TBL] [Abstract][Full Text] [Related]
14. [Cancer breakthrough pain. Indications for rapidly effective opioids].
Kessler J; Bardenheuer HJ
Anaesthesist; 2011 Jul; 60(7):674-82. PubMed ID: 21491140
[TBL] [Abstract][Full Text] [Related]
15. Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.
Elsner F; Zeppetella G; Porta-Sales J; Tagarro I
Clin Drug Investig; 2011; 31(9):605-18. PubMed ID: 21819159
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
Gombert-Handoko KB
Clin Ther; 2014 Nov; 36(11):1704. PubMed ID: 25048312
[No Abstract] [Full Text] [Related]
17. Fentanyl for breakthrough pain: a systematic review.
Davis MP
Expert Rev Neurother; 2011 Aug; 11(8):1197-216. PubMed ID: 21797660
[TBL] [Abstract][Full Text] [Related]
18. [Fentanyl: fast and furious?].
Meissner W; Sabatowski R
Anaesthesist; 2013 Jun; 62(6):429-30. PubMed ID: 23748418
[No Abstract] [Full Text] [Related]
19. The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients.
Brząkała J; Leppert W
Pharmacol Rep; 2019 Jun; 71(3):438-442. PubMed ID: 31003154
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of adult breakthrough cancer pain.
Doulton B
Can Fam Physician; 2014 Dec; 60(12):1111-4, e585-9. PubMed ID: 25500600
[No Abstract] [Full Text] [Related]
[Next] [New Search]
